Literature DB >> 32373658

Parkinsonism Versus Concomitant Parkinson's Disease in Fragile X-Associated Tremor/Ataxia Syndrome.

María Jimena Salcedo-Arellano1,2,3,4, Marisol Wendy Wolf-Ochoa3,4, Tiffany Hong3,4, Sarwat Amina3,4, Flora Tassone2,5, Mirna Lechpammer4, Randi Hagerman1,2, Verónica Martínez-Cerdeño2,3,4.   

Abstract

BACKGROUND: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder associated with premutation alleles (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. FXTAS is characterized by the presence of ubiquitin-positive inclusions in neurons and astrocytes and by cerebellar tremor and ataxia. Parkinsonism has been reported in FXTAS, but most patients lack the characteristic rest tremor and severe rigidity seen in idiopathic Parkinson's disease (PD).
OBJECTIVE: To describe the frequency of concomitant PD in FXTAS.
METHODS: We reviewed the medical record of 40 deceased patients diagnosed with FXTAS and performed a pathology analysis to confirm both FXTAS and PD.
RESULTS: Clinical histories indicated that 5 FXTAS patients were diagnosed with idiopathic PD and 2 with atypical parkinsonian syndrome. After pathological examination, we found that 7 patients in the PD clinical diagnosis group had dopaminergic neuronal loss; however, only 2 of 7 presented Lewy bodies (LBs) in the substantia nigra. Therefore, a total of 5% of the 40 cohort patients met the pathologic criteria for the concomitant diagnosis of FXTAS and PD. In addition, 2 patients not clinically diagnosed with PD also had nigral neuronal loss with LBs in substantia nigra. In total 10% of these 40 patients had LBs.
CONCLUSION: This report expands our understanding of clinical symptoms and unusual presentations in patients with FXTAS and the concept that the parkinsonism found in FXTAS is sometimes indistinguishable from PD. We propose that FMR1 should be recognized as one of the exceptional genetic causes of parkinsonism with presynaptic dopaminergic loss and LBs.
© 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; fragile X associated tremor/ataxia syndrome; fragile X mental retardation 1 gene; neuropathology; parkinsonism

Year:  2020        PMID: 32373658      PMCID: PMC7197312          DOI: 10.1002/mdc3.12942

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  34 in total

1.  New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS).

Authors:  Jorge L Juncos; Joash T Lazarus; Emily Graves-Allen; Lisa Shubeck; Michelle Rusin; Gloria Novak; Deborah Hamilton; Julia Rohr; Stephanie L Sherman
Journal:  Neurogenetics       Date:  2011-01-29       Impact factor: 2.660

2.  Premutations in the FMR1 gene as a modifying factor in Parkin-associated Parkinson's disease?

Authors:  Katja Hedrich; Peter P Pramstaller; Katrin Stübke; Anja Hiller; Kemal Kabakci; Sabine Purmann; Meike Kasten; Cesa Scaglione; Eberhard Schwinger; Jens Volkmann; Vladimir Kostic; Peter Vieregge; Paolo Martinelli; Giovanni Abbruzzese; Christine Klein; Christine Zühlke
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

3.  Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor-ataxia syndrome.

Authors:  Daniel G Healy; Susan Bressman; John Dickson; Laura Silveira-Moriyama; Susanne A Schneider; Sean S O Sullivan; Luke Massey; Kailash P Bhatia; Karen Shaw; Kailash P Bhatia; Jamshed Bomanji; Nicholas W Wood; Andrew J Lees
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

4.  Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females.

Authors:  Danuta Z Loesch; Flora Tassone; George D Mellick; Malcolm Horne; Justin P Rubio; Minh Q Bui; David Francis; Elsdon Storey
Journal:  Mov Disord       Date:  2018-07       Impact factor: 10.338

5.  FMR1 gray-zone alleles: association with Parkinson's disease in women?

Authors:  Deborah A Hall; Elizabeth Berry-Kravis; Wenting Zhang; Flora Tassone; Elaine Spector; Gary Zerbe; Paul J Hagerman; Bichun Ouyang; Maureen A Leehey
Journal:  Mov Disord       Date:  2011-05-12       Impact factor: 10.338

6.  The new definition and diagnostic criteria of Parkinson's disease.

Authors:  Ronald B Postuma; Daniela Berg; Charles H Adler; Bastiaan R Bloem; Piu Chan; Günther Deuschl; Thomas Gasser; Christopher G Goetz; Glenda Halliday; Lawrence Joseph; Anthony E Lang; Inga Liepelt-Scarfone; Irene Litvan; Kenneth Marek; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern
Journal:  Lancet Neurol       Date:  2016-04-11       Impact factor: 44.182

7.  A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.

Authors:  Flora Tassone; Ruiqin Pan; Khaled Amiri; Annette K Taylor; Paul J Hagerman
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

8.  Parkinsonism, FXTAS, and FMR1 premutations.

Authors:  Mathias Toft; Jan Aasly; Gina Bisceglio; Charles H Adler; Ryan J Uitti; Anna Krygowska-Wajs; Timothy Lynch; Zbigniew K Wszolek; Matthew J Farrer
Journal:  Mov Disord       Date:  2005-02       Impact factor: 10.338

9.  Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.

Authors:  Sébastien Jacquemont; Randi J Hagerman; Maureen A Leehey; Deborah A Hall; Richard A Levine; James A Brunberg; Lin Zhang; Tristan Jardini; Louise W Gane; Susan W Harris; Kristin Herman; James Grigsby; Claudia M Greco; Elizabeth Berry-Kravis; Flora Tassone; Paul J Hagerman
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

10.  Novel parkin mutations detected in patients with early-onset Parkinson's disease.

Authors:  Aida M Bertoli-Avella; José L Giroud-Benitez; Ali Akyol; Egberto Barbosa; Onno Schaap; Herma C van der Linde; Emilia Martignoni; Leonardo Lopiano; Paolo Lamberti; Emiliana Fincati; Angelo Antonini; Fabrizio Stocchi; Pasquale Montagna; Ferdinando Squitieri; Paolo Marini; Giovanni Abbruzzese; Giovanni Fabbrini; Roberto Marconi; Alessio Dalla Libera; Giorgio Trianni; Marco Guidi; Antonio De Gaetano; Gustavo Boff Maegawa; Antonino De Leo; Virgilio Gallai; Giulia de Rosa; Nicola Vanacore; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink; Vincenzo Bonifati
Journal:  Mov Disord       Date:  2005-04       Impact factor: 10.338

View more
  4 in total

Review 1.  The polyG diseases: a new disease entity.

Authors:  Tongling Liufu; Yilei Zheng; Jiaxi Yu; Yun Yuan; Zhaoxia Wang; Jianwen Deng; Daojun Hong
Journal:  Acta Neuropathol Commun       Date:  2022-05-31       Impact factor: 7.578

Review 2.  A Practical Approach to Early-Onset Parkinsonism.

Authors:  Giulietta M Riboldi; Emanuele Frattini; Edoardo Monfrini; Steven J Frucht; Alessio Di Fonzo
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

Review 3.  Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications.

Authors:  Ana Maria Cabal-Herrera; Nattaporn Tassanakijpanich; Maria Jimena Salcedo-Arellano; Randi J Hagerman
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

4.  Case Report: Coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome.

Authors:  Maria Jimena Salcedo-Arellano; Desiree Sanchez; Jun Yi Wang; Yingratana A McLennan; Courtney Jessica Clark; Pablo Juarez; Andrea Schneider; Flora Tassone; Randi J Hagerman; Verónica Martínez-Cerdeño
Journal:  Front Neurosci       Date:  2021-09-17       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.